News Industry News New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events September 08, 2015
News Industry News Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant July 28, 2015
News Industry News First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit June 09, 2015
News Daily News Low Trial Participation Rate of MI Patients Raises Questions of Applicability Todd Neale September 02, 2014
News Daily News El Bajo Índice de Participación del Ensayo de Pacientes IM Plantea Dudas de Aplicabilidad Todd Neale September 02, 2014
CME Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice